IntelliPharmaCeutics International Inc. filed its 20-F on Jan 31, 2013 for the period ending Nov 30, 2012. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -.--% |
|
-11.11% | +6.67% |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 19.39L | |
+55.19% | 81TCr | |
+45.28% | 65TCr | |
-6.09% | 35TCr | |
+21.92% | 34TCr | |
+18.85% | 25TCr | |
+3.23% | 23TCr | |
+13.76% | 22TCr | |
+10.86% | 17TCr | |
-2.78% | 16TCr |
- Stock Market
- Equities
- IPCI.H Stock
- News Intellipharmaceutics International Inc.
- IntelliPharmaCeutics International Inc. Auditor Raises 'Going Concern' Doubt